Valuation: DiaSorin S.p.A.

Market Cap 3.54B 4.03B 3.29B 3.02B 5.67B 388B 5.76B 39.06B 15.26B 191B 15.12B 14.79B 659B P/E 2026 *
19.3x
P/E 2027 * 16.9x
Enterprise Value 4.21B 4.79B 3.91B 3.59B 6.74B 461B 6.85B 46.45B 18.15B 227B 17.98B 17.59B 784B EV / Sales 2026 *
3.43x
EV / Sales 2027 * 3.12x
Free-Float
37.17%
Yield 2026 *
1.97%
Yield 2027 * 2.06%
1 day-0.12%
1 week-3.72%
Current month-1.51%
1 month+0.39%
3 months+11.61%
6 months-8.92%
Current year-2.74%
1 week 66.2
Extreme 66.2
70.46
1 month 66.06
Extreme 66.06
71.78
Current year 52.34
Extreme 52.34
77.64
1 year 52.34
Extreme 52.34
92.32
3 years 52.34
Extreme 52.34
112.35
5 years 52.34
Extreme 52.34
208.8
10 years 49.98
Extreme 49.98
211.8
Manager TitleAgeSince
Chief Executive Officer 60 26/03/2007
Director of Finance/CFO - 01/01/2025
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Director/Board Member 60 28/04/2016
Director/Board Member 63 26/03/2007
Chairman 57 29/04/2022
Date Insider Type Main position Quantity % Market Cap.
24/03/26 Buy

Chief Executive Officer

9,211 0.0165%
28/01/26 Buy

Chief Executive Officer

7,500 0.0134%
08/01/26 Buy

Director

700 0.0013%
Change 5-day change 1-year change 3-year change Capi.($)
-0.12%-3.72%-26.59%-29.02% 4.03B
-1.91%-5.48%+223.87%+298.40% 19.92B
+1.30%-4.25%-44.35%-26.73% 9.25B
+1.05%-2.57%+47.78%+24.15% 6.75B
-3.72%+5.78%+237.00%-22.70% 6.1B
+1.38%+7.00%-15.61%-22.09% 5.53B
-8.03%-14.67%+71.13%+90.53% 4.55B
-0.83%-5.88%-47.37% - 4.42B
-2.24%-2.39%-21.09%-43.53% 2.71B
-11.73%-13.74%-42.08%+168.43% 1.62B
Average -2.49%-3.64%+38.27%+48.60% 6.49B
Weighted average by Cap. -1.54%-3.17%+86.50%+100.02%

Financials

2026 *2027 *
Net sales 1.23B 1.4B 1.14B 1.05B 1.97B 135B 2B 13.55B 5.29B 66.13B 5.24B 5.13B 229B 1.3B 1.49B 1.21B 1.11B 2.09B 143B 2.12B 14.41B 5.63B 70.33B 5.58B 5.46B 243B
Net income 182M 208M 170M 156M 292M 19.99B 297M 2.01B 787M 9.83B 779M 763M 33.98B 205M 234M 191M 175M 329M 22.49B 334M 2.27B 885M 11.06B 877M 858M 38.24B
Net Debt 669M 762M 622M 571M 1.07B 73.36B 1.09B 7.39B 2.89B 36.07B 2.86B 2.8B 125B 539M 614M 502M 460M 865M 59.13B 878M 5.96B 2.33B 29.07B 2.31B 2.26B 101B
Logo DiaSorin S.p.A.
DiaSorin S.p.A. specializes in the development, manufacturing and marketing of in vitro diagnostic reagents. The products are used in treating infectious and viral diseases, thyroid pathologies, cancer, etc. At the end of 2025, the group had 9 production sites located in Italy, the United States (4), Canada, Germany, the United Kingdom and Chine. Net sales are distributed geographically as follows: Italy (15.2%), Europe (24.9%), North America (51.8%), and other (8.1%).
Employees
3,242
Date Price Change Volume
24/07/26 €66.74 -0.12% 151,611
23/07/26 €66.82 -0.27% 116,775
22/07/26 €67.00 -0.62% 153,763
21/07/26 €67.42 -3.96% 279,230
20/07/26 €70.20 +1.27% 105,441
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
14
Last Close Price
66.74EUR
Average target price
70.45EUR
Spread / Average Target
+5.56%

Quarterly revenue - Rate of surprise